Two FTSE 100 growth stocks I’d buy with £2,000 today

These two FTSE 100 (INDEXFTSE: UKX) shares could offer growth at a reasonable price.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

Finding growth shares which trade at fair prices may now be easier after the FTSE 100’s recent pullback. The index fell by as much as 10% from its all-time high and while it has recovered around half of that, buying opportunities are still present.

With that in mind, here are two shares that appear to offer strong growth prospects for the long run. When combined with valuations that could move higher, this means they may be worth buying right now.

Takeover prospects

It’s been a busy few weeks for the management of rare diseases specialist Shire (LSE: SHP). The company has been the subject of takeover talk, with Takeda making three separate bids for the company. All of those have been rejected by the company’s management. However, a further bid from Takeda could be ahead, with industry peer Allergan announcing that it’s not considering making an offer.

Should you invest £1,000 in Smith & Nephew Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Smith & Nephew Plc made the list?

See the 6 stocks

One reason for the rival interest in Shire could be its relatively low valuation. Since it merged with Baxalta, investor sentiment towards the stock has been relatively weak. Even after a share price gain of 23% in the last month, it still has a price-to-earnings (P/E) ratio of around 11.

Given the company’s forecast growth rate of 7-8% over the next two financial years, it may prove to be undervalued. If a further bid is made, the company’s shares could deliver additional capital growth in the short run. And, should no further bids appear, its appeal from a value and growth perspective appears to be high. As such, now could be a sound moment to buy the stock for the long term.

Consistent growth

With the FTSE 100 having been volatile in recent months, investors may begin to place premium valuations on stocks that can offer consistent performance. One such company is medical devices sector specialist Smith & Nephew (LSE: SN). Unlike pharmaceutical stocks, it doesn’t experience a ‘boom and bust’ sales performance. Its sales are usually relatively consistent and this could provide a greater degree of certainty regarding its long-term performance.

Smith & Nephew is forecast to post a rise in its bottom line of 4% in the current year, followed by further growth of 7% next year. While not the highest rate of growth on offer in the FTSE 100, there’s a good chance of it meeting its prospects over the medium term. This reliability could become more highly sought-after by investors if market volatility remains high.

Beyond next year, the company appears to have a solid growth outlook. Demand for its range of products is likely to increase over the coming years as the world’s population increases in size and age. Given this potential tailwind, a P/E ratio of 21 seems to be a fair price to pay for the stock relative to its industry peers.


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens has no position in any of the shares mentioned. The Motley Fool UK has recommended Shire. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

Spare £5k? Here’s how long it would take to generate a second income of £5k every year!

Christopher Ruane explains the maths behind building a second income from dividend shares, as well as some of the opportunities…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

As the FTSE 100 hits an all-time high, is it too late to get in on the boom?

The FTSE 100 index of leading British shares hit a new all-time high in the past week. Our writer explains…

Read more »

Close-up of British bank notes
Investing Articles

3 shares to consider for long-term passive income

Christopher Ruane thinks investors on the hunt for passive income streams should consider this diverse trio of dividend-paying shares.

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

Here are the latest dividend yield forecasts for Legal & General, Aviva, and M&G shares

If someone’s looking for high dividend yields on the London Stock Exchange, these three Footsie financial stocks are definitely worth…

Read more »

Pakistani multi generation family sitting around a table in a garden in Middlesbourgh, North East of England.
Growth Shares

Up 68% but still yielding 7.1%, I’ve been loading up on Aberdeen shares

The FTSE 250 is loaded full of great businesses with significant growth potential. This writer believes Aberdeen shares to be…

Read more »

Abstract bull climbing indicators on stock chart
Investing Articles

Is the Vodafone resurgence on, as results and a buyback boost the share price?

The Vodafone share price has been ticking up in 2025. Is that a sign the company's bold restructuring plans are…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

The Legal & General share price is rising. Will it soon be too late to bag big dividends?

The Legal & General share price has had an unremarkable decade, but it currently has one of the Footsie's biggest…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

Are dividend shares a good way of getting rich? Here’s what Warren Buffett thinks

Dividend shares can be great passive income investments, but when it comes to building wealth, Warren Buffett is clear on…

Read more »